Teri-EM (Emcure Pharmaceuticals Pty Ltd)
Product name
Teri-EM
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
100 working days (255)
Active ingredients
teriflunomide
Registration type
New generic medicine
Indication
Teri-EM (film coated tablets) is indicated for the treatment of patients with relapsing forms of Multiple Sclerosis to reduce the frequency of clinical relapses and to delay the progression of physical disability.